This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Improving Adult Immunization across the Continuum of Care: Making the Most of Opportunities in the Ambulatory Care Setting

Improving Adult Immunization across the Continuum of Care: Making the Most of Opportunities in the Ambulatory Care Setting

Format

Slide Lecture Series

Time to Complete

1.50 hours

Released

March 1, 2016

Expires

May 16, 2017
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM

Pharmacy Credits

Pharmacists may earn 1.50 CE Credits (0.15 CEUs) by completing this course on the American Society of Health-System Pharmacists (ASHP) website. Please click here to go to the course (you will leave the myCME website). Your certificate will save on ASHP.org and will not be included in your myCME CME History.

Accredited Provider

This continuing medical education activity is provided by the American Society of Health-System Pharmacists (ASHP).

Commercial Supporter

Supported by an educational grant from Merck.

Program Description

According to the National Foundation for Infectious Diseases (NFID), more than 50,000 adults in the United States die from vaccine-preventable diseases or their complications each year, and nearly 36,000 people die from complications of seasonal influenza. The current comprehensive U.S. adult immunization schedule includes vaccination for 16 infectious diseases. Despite the availability of these vaccines, many adults remain unvaccinated against preventable infectious illnesses.

Health care professionals who work in the ambulatory care setting have an opportunity to screen unimmunized patients at risk for vaccine-preventable diseases and intervene. In order to be most effective, health care professionals must remain abreast of the frequently updated recommendations for adult immunization from the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices. This activity highlights the latest recommendations for four important adult vaccines: influenza; pneumococcal; herpes zoster; and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines, and will discuss vaccination strategies for specific immunocompromised patients and immunization considerations for health care personnel are also discussed.

Intended Audience

This continuing education activity was planned to meet the needs of pharmacists and physicians in a variety of practice settings, including large and small health systems, ambulatory care clinics, managed care organizations, and academia. The activity is particularly beneficial for pharmacists, physicians, clinical specialists, managers, leaders, and educators who are interested in improving adult immunization.

Educational Objectives

At the conclusion of this application-based educational activity, participants should be able to:

  • Outline current adult vaccination recommendations for the influenza; pneumococcal; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap); and herpes zoster vaccines
  • Provide recommendations for vaccinations in adult immunocompromised patients
  • Recommend vaccines for healthcare personnel and strategies to optimize coverage
  • Outline approaches to improve adult vaccination rates across all populations in the ambulatory care setting

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

Faculty

Dennis M. Williams, Pharm.D., BCPS, AE-C, FASHP, FCCP, FAPhA (Activity Chair)
Associate Professor and Vice Chair
Division of Pharmacotherapy and Experimental Therapeutics
UNC Eshelman School of Pharmacy
University of North Carolina
Chapel Hill, North Carolina

Dr. Williams declares his spouse is a stockholder of GlaxoSmithKline plc.
David J. Weber, M.D., M.P.H., FIDSA, FSHEA
Professor of Medicine and Pediatrics, UNC School of Medicine
Professor of Epidemiology, UNC School of Public Health
Associate Chief Medical Officer, UNC Health Care
Medical Director, Hospital Epidemiology and Occupational Health
University of North Carolina
Chapel Hill, North Carolina

Dr. Weber declares he is a speaker and consultant for Merck and Pfizer, Inc.

Planners' and Managers' Disclosures

The planners and managers reported no financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Society of Health-System Pharmacists designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Instructions

In order to receive credit, participants must complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact elearning@ashp.org.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue